T/CACM 1273-2019 Active Group standards

T/CACM 1273-2019 Chinese Internal Medicine Guideline for Acute Myocardial Infarction

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CACM 1273-2019

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medicine

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2019-01-30

Implement Date: 2020-01-01

Scope

Main technical content: The key to treating acute myocardial infarction is to open the infarction-related coronary arteries early, quickly, and completely. The prevention, diagnosis, and treatment recommendations mainly based on traditional Chinese medicine recommended in this guideline cannot completely replace modern medical treatment methods. This guideline proposes recommendations for the diagnosis and treatment of AMI based on traditional Chinese and Western medicine, syndrome differentiation and treatment, recommended traditional Chinese medicines, other therapies, symptomatic treatment, and prevention and care. This guideline is suitable for people aged 18 and above. Children, pregnant and postpartum women, and patients with severe organ dysfunction need to be further carefully evaluated when applying this guideline. This guideline is suitable for clinicians working in cardiology, emergency departments, geriatrics, traditional Chinese medicine, and integrated traditional and Western medicine departments.